The gut microbiome modulates colon tumorigenesis

Area of Science:

• Microbiology
• Gastroenterology
• Oncology

Background:

• The gut microbiome plays a crucial role in intestinal function.
• Disruptions in the gut microbiome are increasingly linked to colorectal cancer (CRC) development.
• The precise role of the gut microbiome in CRC pathogenesis remains unclear.

Purpose of the Study:

• To investigate the role of the gut microbiome in the development of inflammation-associated colorectal cancer.
• To determine if alterations in the gut microbiome actively drive tumorigenesis.
• To explore the potential of microbiome-targeted interventions for CRC prevention.

Main Methods:

• Characterization of the gut microbiome in a murine model of inflammation-associated CRC.
• Comparative analysis of microbial communities in tumor-bearing and healthy mice.
• Conventionalization of germfree mice with microbiota from tumor-bearing or healthy donors.
• Assessment of tumor development and microbial composition.
• Intervention with antibiotics to modulate the gut microbiome.

Main Results:

• Significant alterations in gut microbial composition were observed during CRC development, with enrichment of Bacteroides, Odoribacter, and Akkermansia, and depletion of Prevotellaceae and Porphyromonadaceae.
• Colonization with microbiota from tumor-bearing mice significantly increased tumorigenesis in germfree recipients.
• Antibiotic treatment dramatically reduced tumor number and size.
• Germfree mice colonized with microbiota from tumor-bearing mice showed a higher abundance of tumor-associated microbial populations.

Conclusions:

• The gut microbiome composition dynamically changes during CRC development and actively contributes to tumorigenesis.
• Targeting the gut microbiome represents a promising strategy for the prevention and treatment of colorectal cancer.